SCHEMBL6944914

SCHEMBL6944914

CCOC(=O)CC1=NN(c2ccc(C(=O)O)cc2)C(=O)/C1=C/Nc1ccccc1CC

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.53
KMT2A Q03164 7/20 0.53
ALDH1A1 P00352 6/20 0.53
MAPT P10636 5/20 0.53
MAPK1 P28482 2/20 0.53
HPGD P15428 4/20 0.49
KDM4E B2RXH2 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
KAT8 Q9H7Z6 8/20 0.48
THRB P10828 2/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EP300 Q09472 4/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944916 1.00 MEN1 (0.53) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL8428067 0.96 ALDH1A1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL8428068 0.96 ALDH1A1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL8428071 0.90 ALDH1A1 (0.48) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6952104 0.88 MAPT (0.50) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6952099 0.88 MAPT (0.50) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6951587 0.88 MAPT (0.50) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6951586 0.88 MAPT (0.50) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6946842 0.88 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL6946840 0.88 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed